0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pet Drug and Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-34Z7848
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global and China Pet Drug and Vaccine Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Pet Drug and Vaccine Market Research Report 2025

Code: QYRE-Auto-34Z7848
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pet Drug and Vaccine Market Size

The global market for Pet Drug and Vaccine was valued at US$ 17380 million in the year 2024 and is projected to reach a revised size of US$ 27720 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Pet Drug and Vaccine Market

Pet Drug and Vaccine Market

In this report, we study the Veterinary Products for Companion Animals mainly medicines, vaccines and others.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 458%.
This report aims to provide a comprehensive presentation of the global market for Pet Drug and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Drug and Vaccine.
The Pet Drug and Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Drug and Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Drug and Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pet Drug and Vaccine Market Report

Report Metric Details
Report Name Pet Drug and Vaccine Market
Accounted market size in year US$ 17380 million
Forecasted market size in 2031 US$ 27720 million
CAGR 7.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Drugs
  • Vaccine
Segment by Application
  • Dogs
  • Cats
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Parnell
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pet Drug and Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pet Drug and Vaccine Market growing?

Ans: The Pet Drug and Vaccine Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Pet Drug and Vaccine Market size in 2031?

Ans: The Pet Drug and Vaccine Market size in 2031 will be US$ 27720 million.

What is the Pet Drug and Vaccine Market share by region?

Ans: According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Pet Drug and Vaccine Market report?

Ans: The main players in the Pet Drug and Vaccine Market are Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Parnell

What are the Application segmentation covered in the Pet Drug and Vaccine Market report?

Ans: The Applications covered in the Pet Drug and Vaccine Market report are Dogs, Cats, Other

What are the Type segmentation covered in the Pet Drug and Vaccine Market report?

Ans: The Types covered in the Pet Drug and Vaccine Market report are Drugs, Vaccine

Recommended Reports

Pet Veterinary Drugs

Pet Healthcare Products

Pet Nutrition & Accessories

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Drug and Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Vaccine
1.3 Market by Application
1.3.1 Global Pet Drug and Vaccine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Drug and Vaccine Market Perspective (2020-2031)
2.2 Global Pet Drug and Vaccine Growth Trends by Region
2.2.1 Global Pet Drug and Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pet Drug and Vaccine Historic Market Size by Region (2020-2025)
2.2.3 Pet Drug and Vaccine Forecasted Market Size by Region (2026-2031)
2.3 Pet Drug and Vaccine Market Dynamics
2.3.1 Pet Drug and Vaccine Industry Trends
2.3.2 Pet Drug and Vaccine Market Drivers
2.3.3 Pet Drug and Vaccine Market Challenges
2.3.4 Pet Drug and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Drug and Vaccine Players by Revenue
3.1.1 Global Top Pet Drug and Vaccine Players by Revenue (2020-2025)
3.1.2 Global Pet Drug and Vaccine Revenue Market Share by Players (2020-2025)
3.2 Global Pet Drug and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pet Drug and Vaccine Revenue
3.4 Global Pet Drug and Vaccine Market Concentration Ratio
3.4.1 Global Pet Drug and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Drug and Vaccine Revenue in 2024
3.5 Global Key Players of Pet Drug and Vaccine Head office and Area Served
3.6 Global Key Players of Pet Drug and Vaccine, Product and Application
3.7 Global Key Players of Pet Drug and Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Drug and Vaccine Breakdown Data by Type
4.1 Global Pet Drug and Vaccine Historic Market Size by Type (2020-2025)
4.2 Global Pet Drug and Vaccine Forecasted Market Size by Type (2026-2031)
5 Pet Drug and Vaccine Breakdown Data by Application
5.1 Global Pet Drug and Vaccine Historic Market Size by Application (2020-2025)
5.2 Global Pet Drug and Vaccine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pet Drug and Vaccine Market Size (2020-2031)
6.2 North America Pet Drug and Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pet Drug and Vaccine Market Size by Country (2020-2025)
6.4 North America Pet Drug and Vaccine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Drug and Vaccine Market Size (2020-2031)
7.2 Europe Pet Drug and Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pet Drug and Vaccine Market Size by Country (2020-2025)
7.4 Europe Pet Drug and Vaccine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Drug and Vaccine Market Size (2020-2031)
8.2 Asia-Pacific Pet Drug and Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pet Drug and Vaccine Market Size by Region (2020-2025)
8.4 Asia-Pacific Pet Drug and Vaccine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Drug and Vaccine Market Size (2020-2031)
9.2 Latin America Pet Drug and Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pet Drug and Vaccine Market Size by Country (2020-2025)
9.4 Latin America Pet Drug and Vaccine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Drug and Vaccine Market Size (2020-2031)
10.2 Middle East & Africa Pet Drug and Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pet Drug and Vaccine Market Size by Country (2020-2025)
10.4 Middle East & Africa Pet Drug and Vaccine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Pet Drug and Vaccine Introduction
11.1.4 Zoetis Revenue in Pet Drug and Vaccine Business (2020-2025)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Drug and Vaccine Introduction
11.2.4 Boehringer Ingelheim Revenue in Pet Drug and Vaccine Business (2020-2025)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Details
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Pet Drug and Vaccine Introduction
11.3.4 Merck Animal Health Revenue in Pet Drug and Vaccine Business (2020-2025)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Details
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Pet Drug and Vaccine Introduction
11.4.4 Elanco Animal Health Revenue in Pet Drug and Vaccine Business (2020-2025)
11.4.5 Elanco Animal Health Recent Development
11.5 Virbac
11.5.1 Virbac Company Details
11.5.2 Virbac Business Overview
11.5.3 Virbac Pet Drug and Vaccine Introduction
11.5.4 Virbac Revenue in Pet Drug and Vaccine Business (2020-2025)
11.5.5 Virbac Recent Development
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Company Details
11.6.2 Dechra Veterinary Products Business Overview
11.6.3 Dechra Veterinary Products Pet Drug and Vaccine Introduction
11.6.4 Dechra Veterinary Products Revenue in Pet Drug and Vaccine Business (2020-2025)
11.6.5 Dechra Veterinary Products Recent Development
11.7 Ceva
11.7.1 Ceva Company Details
11.7.2 Ceva Business Overview
11.7.3 Ceva Pet Drug and Vaccine Introduction
11.7.4 Ceva Revenue in Pet Drug and Vaccine Business (2020-2025)
11.7.5 Ceva Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Details
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Pet Drug and Vaccine Introduction
11.8.4 Vetoquinol Revenue in Pet Drug and Vaccine Business (2020-2025)
11.8.5 Vetoquinol Recent Development
11.9 Meiji
11.9.1 Meiji Company Details
11.9.2 Meiji Business Overview
11.9.3 Meiji Pet Drug and Vaccine Introduction
11.9.4 Meiji Revenue in Pet Drug and Vaccine Business (2020-2025)
11.9.5 Meiji Recent Development
11.10 Ouro Fino Saude
11.10.1 Ouro Fino Saude Company Details
11.10.2 Ouro Fino Saude Business Overview
11.10.3 Ouro Fino Saude Pet Drug and Vaccine Introduction
11.10.4 Ouro Fino Saude Revenue in Pet Drug and Vaccine Business (2020-2025)
11.10.5 Ouro Fino Saude Recent Development
11.11 Parnell
11.11.1 Parnell Company Details
11.11.2 Parnell Business Overview
11.11.3 Parnell Pet Drug and Vaccine Introduction
11.11.4 Parnell Revenue in Pet Drug and Vaccine Business (2020-2025)
11.11.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pet Drug and Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Drugs
 Table 3. Key Players of Vaccine
 Table 4. Global Pet Drug and Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pet Drug and Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pet Drug and Vaccine Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pet Drug and Vaccine Market Share by Region (2020-2025)
 Table 8. Global Pet Drug and Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pet Drug and Vaccine Market Share by Region (2026-2031)
 Table 10. Pet Drug and Vaccine Market Trends
 Table 11. Pet Drug and Vaccine Market Drivers
 Table 12. Pet Drug and Vaccine Market Challenges
 Table 13. Pet Drug and Vaccine Market Restraints
 Table 14. Global Pet Drug and Vaccine Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pet Drug and Vaccine Market Share by Players (2020-2025)
 Table 16. Global Top Pet Drug and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug and Vaccine as of 2024)
 Table 17. Ranking of Global Top Pet Drug and Vaccine Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pet Drug and Vaccine Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pet Drug and Vaccine, Headquarters and Area Served
 Table 20. Global Key Players of Pet Drug and Vaccine, Product and Application
 Table 21. Global Key Players of Pet Drug and Vaccine, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pet Drug and Vaccine Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pet Drug and Vaccine Revenue Market Share by Type (2020-2025)
 Table 25. Global Pet Drug and Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pet Drug and Vaccine Revenue Market Share by Type (2026-2031)
 Table 27. Global Pet Drug and Vaccine Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pet Drug and Vaccine Revenue Market Share by Application (2020-2025)
 Table 29. Global Pet Drug and Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pet Drug and Vaccine Revenue Market Share by Application (2026-2031)
 Table 31. North America Pet Drug and Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pet Drug and Vaccine Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pet Drug and Vaccine Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pet Drug and Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pet Drug and Vaccine Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pet Drug and Vaccine Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pet Drug and Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pet Drug and Vaccine Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pet Drug and Vaccine Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pet Drug and Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pet Drug and Vaccine Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pet Drug and Vaccine Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pet Drug and Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pet Drug and Vaccine Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pet Drug and Vaccine Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Zoetis Company Details
 Table 47. Zoetis Business Overview
 Table 48. Zoetis Pet Drug and Vaccine Product
 Table 49. Zoetis Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 50. Zoetis Recent Development
 Table 51. Boehringer Ingelheim Company Details
 Table 52. Boehringer Ingelheim Business Overview
 Table 53. Boehringer Ingelheim Pet Drug and Vaccine Product
 Table 54. Boehringer Ingelheim Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 55. Boehringer Ingelheim Recent Development
 Table 56. Merck Animal Health Company Details
 Table 57. Merck Animal Health Business Overview
 Table 58. Merck Animal Health Pet Drug and Vaccine Product
 Table 59. Merck Animal Health Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 60. Merck Animal Health Recent Development
 Table 61. Elanco Animal Health Company Details
 Table 62. Elanco Animal Health Business Overview
 Table 63. Elanco Animal Health Pet Drug and Vaccine Product
 Table 64. Elanco Animal Health Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 65. Elanco Animal Health Recent Development
 Table 66. Virbac Company Details
 Table 67. Virbac Business Overview
 Table 68. Virbac Pet Drug and Vaccine Product
 Table 69. Virbac Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 70. Virbac Recent Development
 Table 71. Dechra Veterinary Products Company Details
 Table 72. Dechra Veterinary Products Business Overview
 Table 73. Dechra Veterinary Products Pet Drug and Vaccine Product
 Table 74. Dechra Veterinary Products Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 75. Dechra Veterinary Products Recent Development
 Table 76. Ceva Company Details
 Table 77. Ceva Business Overview
 Table 78. Ceva Pet Drug and Vaccine Product
 Table 79. Ceva Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 80. Ceva Recent Development
 Table 81. Vetoquinol Company Details
 Table 82. Vetoquinol Business Overview
 Table 83. Vetoquinol Pet Drug and Vaccine Product
 Table 84. Vetoquinol Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 85. Vetoquinol Recent Development
 Table 86. Meiji Company Details
 Table 87. Meiji Business Overview
 Table 88. Meiji Pet Drug and Vaccine Product
 Table 89. Meiji Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 90. Meiji Recent Development
 Table 91. Ouro Fino Saude Company Details
 Table 92. Ouro Fino Saude Business Overview
 Table 93. Ouro Fino Saude Pet Drug and Vaccine Product
 Table 94. Ouro Fino Saude Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 95. Ouro Fino Saude Recent Development
 Table 96. Parnell Company Details
 Table 97. Parnell Business Overview
 Table 98. Parnell Pet Drug and Vaccine Product
 Table 99. Parnell Revenue in Pet Drug and Vaccine Business (2020-2025) & (US$ Million)
 Table 100. Parnell Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Pet Drug and Vaccine Picture
 Figure 2. Global Pet Drug and Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pet Drug and Vaccine Market Share by Type: 2024 VS 2031
 Figure 4. Drugs Features
 Figure 5. Vaccine Features
 Figure 6. Global Pet Drug and Vaccine Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pet Drug and Vaccine Market Share by Application: 2024 VS 2031
 Figure 8. Dogs Case Studies
 Figure 9. Cats Case Studies
 Figure 10. Other Case Studies
 Figure 11. Pet Drug and Vaccine Report Years Considered
 Figure 12. Global Pet Drug and Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Pet Drug and Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pet Drug and Vaccine Market Share by Region: 2024 VS 2031
 Figure 15. Global Pet Drug and Vaccine Market Share by Players in 2024
 Figure 16. Global Top Pet Drug and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug and Vaccine as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Pet Drug and Vaccine Revenue in 2024
 Figure 18. North America Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Pet Drug and Vaccine Market Share by Country (2020-2031)
 Figure 20. United States Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pet Drug and Vaccine Market Share by Country (2020-2031)
 Figure 24. Germany Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pet Drug and Vaccine Market Share by Region (2020-2031)
 Figure 32. China Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pet Drug and Vaccine Market Share by Country (2020-2031)
 Figure 40. Mexico Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pet Drug and Vaccine Market Share by Country (2020-2031)
 Figure 44. Turkey Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Pet Drug and Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Zoetis Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 48. Boehringer Ingelheim Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 49. Merck Animal Health Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 50. Elanco Animal Health Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 51. Virbac Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 52. Dechra Veterinary Products Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 53. Ceva Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 54. Vetoquinol Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 55. Meiji Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 56. Ouro Fino Saude Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 57. Parnell Revenue Growth Rate in Pet Drug and Vaccine Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS